Indian Pharma Looks To Move Beyond Generics

Specialty Boost For Sun Pharma Amid Generics Woes

Talking Point: Path Ahead For U.S. Generic Market And Indian Pharma Sector

Are Generic Drugs Safe? Meet The Author of 'Bottle of Lies: Ranbaxy and the Dark Side of Indian Pharma'

Dr Reddy's Chairman ON How Indian Pharma Industry Can Move UP The Value Chain

ALTBalaji Looks To Move Beyond Hindi

SAY NI DOK | Generics Awareness Month 2021

Why are docs raging against Aamir's generics proposal?

Gilead inks deals with generics drugmakers to supply remdesivir for 127 countries

Biocon sees FY20 as a strong year in terms of generics biz growth in US

Big Pharma Rallies Against Medicare's Historic Move to Control Drug Prices

Aim is to move above 20% EBITDA, says GSK Pharma

Price Curbs Hurting Indian Pharma Companies

Why Markets Favour MNCs Over Indian Pharma

U.S. Regulatory Hurdles For Indian Pharma

Indian Pharma First To Find Cure To "Zika Virus"

COVID-19 : Indian Pharma Industry Capable Of Producing COVID-19 Vaccine - Bill Gates || Oneindia

Podcast | Katherine Eban, the author of Bottle of Lies: Ranbaxy and the Dark Side of Indian Pharma

Indian Pharma Firms Face US Lawsuit

Job Series (Part 4): How Indian pharma companies are helping aspirants get employed

US states file lawsuit against pharma firms over inflated prices, profiteering; 7 Indian companies on the list

PNB's Growth Outlook For FY25 | NDTV Profit

Arvind SmartSpaces Q4 Revenue Rise 26.6% At ₹117.4 Cr | NDTV Profit

Key Growth Levers For Greaves Cotton And India Shelter | NDTV Profit

Tata Motors Q4 May Rise 25% to ₹6966 Cr | NDTV Profit

What Does FY25 Have In Store For CAMS? | NDTV Profit

VST Tillers Q4: Revenue Down 15% To ₹273 Cr | NDTV Profit